Aspirin's ability to protect against colorectal cancer may depend on inflammatory pathways

The reduced risk of colorectal cancer associated with taking aspirin or other NSAIDs may be confined to individuals already at risk because of elevations in a particular inflammatory factor in the blood. Researchers report finding that higher baseline levels of a novel inflammatory marker indicated increased risk of developing colorectal tumors and predicted who might benefit from taking aspirin or NSAIDs.

Read the whole article on Science Daily

More from Science Daily